Usha Gungabissoon

Prevalence, Risk Factors, Clinical Consequences, and Treatment of Enteral Feed Intolerance During Critical Illness

Usha Gungabissoon, Kimberley Hacquoil, Chanchal Bains et al. · Journal of Parenteral and Enteral Nutrition · 2014 · 285 citations

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial

Vincent Meininger, Angela Genge, Leonard H van den Berg et al. · The Lancet Neurology · 2017 · 82 citations · Full text

Amyotrophic Lateral Sclerosis, Neurological Disorder, Clinical Neurology +4

Guidelines for the control of hepatitis A virus infection.

Natasha S. Crowcroft, Bradley J. Walsh, Katy Davison et al. · PubMed · 2001 · 80 citations

Vaccination, Vaccine Safety, Infectious Disease Epidemiology +15

Dementia prevalence and incidence in a federation of European Electronic Health Record databases: The European Medical Informatics Framework resource

Gayan Perera, Lars Pedersen, David Ansel et al. · Alzheimer s & Dementia · 2017 · 60 citations · Full text

Identifying risk factors for progression to critical care admission and death among individuals with acute pancreatitis: a record linkage analysis of Scottish healthcare databases

Damian J. Mole, Usha Gungabissoon, Philip E. Johnston et al. · BMJ Open · 2016 · 34 citations · Full text